SAVE THE DATE:Dana-Farber/Children’s Hospital Cancer Care is hosting the 42nd Congress of the International Society of Paediatric Oncology (SIOP). The largest pediatric oncology meeting in the world, SIOP is returning to the United States for the first time in 17 years.
Dates:Thursday, Oct. 21, through Sunday, Oct. 24, 2010Media room will be available 7:30 a.m. to 6 p.m., Thursday through Saturday, and 8 a.m. to 3 p.m. Sunday.
Location: John B. Hynes Veterans Memorial Convention CenterBoston, Massachusetts, USA
Highlights:Dana-Farber/Children’s Hospital Cancer Care experts are leading a number of important symposia and providing keynote presentations including:
Gene Therapy and Pediatric Oncology: “Somatic Cell Reprogramming to Facilitate Genetic Correction in Fanconi Anemia”David Williams, MDFriday, Oct. 22, 10:30-Noon, Ballroom A
Ethical Issues in Pediatric Oncology: “Cancer Patients’ and Parents’ Attitudes towards Banking of Tissues for Research”Steven Joffe, MD, MPHFriday, Oct. 22, 1:30-3:00, Room 309
“Knowledge and Understanding of the Informed Consent Process among Parents of Children Enrolled on Cancer Clinical Trials”Steven Joffe, MD, MPHSaturday, Oct. 23, 10:30-Noon, Room 310
Childhood Cancer Support Groups“DF/CHCC Pediatric Patient and Family Advisory Council –Where We Started, Where We Are and How We Got Here”Chris Reilly, Dana-Farber/Children’s Hospital Cancer CareFriday, Oct. 22, 1:30-3 p.m., Room 206
Future of Stem Cell Transplantation key note: “Modeling Bone Marrow Failure Syndromes with Induced Pluripotent Stem Cells”George Daley, MD, PhD, Dana-Farber/Children’s Hospital Cancer CareSunday, Oct. 24, 3-3:30 p.m., Auditorium
Media Registration:To learn more about the meeting or to register for the press room, contact Teresa Herbert, Senior Media Relations Specialist, Dana-Farber Cancer Institute [email protected]; 617-632-4090
Dana-Farber Cancer Institute (www.dana-farber.org) is a principal teaching affiliate of the Harvard Medical School and is among the leading cancer research and care centers in the United States. It is a founding member of the Dana-Farber/Harvard Cancer Center (DF/HCC), designated a comprehensive cancer center by the National Cancer Institute. It provides adult cancer care with Brigham and Women’s Hospital as Dana-Farber/Brigham and Women’s Cancer Center and it provides pediatric care with Children’s Hospital Boston as Dana-Farber/Children’s Hospital Cancer Center. Dana-Farber is the top ranked cancer center in New England, according to U.S. News & World Report, and one of the largest recipients among independent hospitals of National Cancer Institute and National Institutes of Health grant funding.
Children’s Hospital Boston is home to the world’s largest research enterprise based at a pediatric medical center, where its discoveries have benefited both children and adults since 1869. More than 1,100 scientists, including nine members of the National Academy of Sciences, 12 members of the Institute of Medicine and 13 members of the Howard Hughes Medical Institute comprise Children’s research community. Founded as a 20-bed hospital for children, Children's Hospital Boston today is a 392-bed comprehensive center for pediatric and adolescent health care grounded in the values of excellence in patient care and sensitivity to the complex needs and diversity of children and families. Children's also is the primary pediatric teaching affiliate of Harvard Medical School. For more information about the hospital and its research visit: www.childrenshospital.org/newsroom.
RSS